Joint Agreements. 1. This Agreement shall be governed by the laws of the State of Delaware. 2. This Agreement (exclusive of Sections A.9. and B.9.) shall inure to the benefit of and be binding upon Matrix and Chiron and their respective Affiliates, successors and assigns, including any successor to Matrix or Chiron or substantially all of Matrix's or Chiron's assets or business, by merger, consolidation, purchase of assets, purchase of stock or otherwise. 3. All notices hereunder shall be in writing and shall be deemed to have been duly given when delivered by messenger, transmitted by facsimile transmission (with receipt confirmed), or five days after being mailed by registered or certified mail, postage prepaid, as follows: a. If to Matrix: Matrix Pharmaceutical, Inc. ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ With a copy to: Pillsbury Winthrop LLP ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, ▇▇. b. If to Chiron: Attn: ▇▇▇▇ ▇▇▇▇▇, President and Chief Executive Officer 4. If any provision of this Agreement is determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by applicable law. This Agreement may be executed in several counterparts, all of which together shall constitute one and the same agreement. 5. This Agreement contains the entire agreement between the parties concerning the subject matter hereof and supersedes all previous agreements, written or oral, relating to the subject matter hereof. No modification of this Agreement or waiver of the terms and conditions hereof will be binding unless approved by the parties in writing. 6. The restrictions and covenants set forth in this Agreement shall terminate and be of no further force and effect as of the second anniversary of the date hereof.
Appears in 1 contract
Sources: Confidentiality Agreement (Matrix Pharmaceutical Inc/De)
Joint Agreements. 1. This Agreement shall be governed by the laws of the State of Delaware.
2. This Agreement (exclusive of Sections A.9. and B.9.) shall inure to the benefit of and be binding upon Matrix and Chiron and their respective Affiliates, successors and assigns, including any successor to Matrix or Chiron or substantially all of Matrix's or Chiron's assets or business, by merger, consolidation, purchase of assets, purchase of stock or otherwise.
3. All notices hereunder shall be in writing and shall be deemed to have been duly given when delivered by messenger, transmitted by facsimile transmission (with receipt confirmed), or five days after being mailed by registered or certified mail, postage prepaid, as follows:
a. If to Matrix: Matrix Pharmaceutical, Inc. ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ With a copy to: Pillsbury Winthrop LLP ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attn: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, ▇▇.
b. If to Chiron: Attn: ▇▇▇▇ ▇▇▇▇▇, President and Chief Executive Officer
4. If any provision of this Agreement is determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted by applicable law. This Agreement may be executed in several counterparts, all of which together shall constitute one and the same agreement.
5. This Agreement contains the entire agreement between the parties concerning the subject matter hereof and supersedes all previous agreements, written or oral, relating to the subject matter hereof. No modification of this Agreement or waiver of the terms and conditions hereof will be binding unless approved by the parties in writing.
6. The restrictions and covenants set forth in this Agreement shall terminate and be of no further force and effect as of the second anniversary of the date hereof.
Appears in 1 contract
Sources: Confidentiality Agreement (Matrix Pharmaceutical Inc/De)